Increased risk of breast cancer associated with long-term shift work in Canada.

PubWeight™: 2.24‹?› | Rank: Top 2%

🔗 View Article (PMID 23817841)

Published in Occup Environ Med on July 01, 2013

Authors

Anne Grundy1, Harriet Richardson, Igor Burstyn, Caroline Lohrisch, Sandip K SenGupta, Agnes S Lai, Derrick Lee, John J Spinelli, Kristan J Aronson

Author Affiliations

1: Department of Public Health Sciences and Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.

Articles citing this

Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health (2014) 2.34

Light at night and breast cancer risk among California teachers. Epidemiology (2014) 2.06

Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin (2013) 1.31

Circadian misalignment and health. Int Rev Psychiatry (2014) 1.08

The association between different night shiftwork factors and breast cancer: a case-control study. Br J Cancer (2013) 0.88

Night work and breast cancer in women: a Swedish cohort study. BMJ Open (2015) 0.87

Intermittent Fasting and Human Metabolic Health. J Acad Nutr Diet (2015) 0.86

Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis. Onco Targets Ther (2015) 0.82

Timing Matters: Circadian Rhythm in Sepsis, Obstructive Lung Disease, Obstructive Sleep Apnea, and Cancer. Ann Am Thorac Soc (2016) 0.81

Sleep interruption associated with house staff work schedules alters circadian gene expression. Sleep Med (2015) 0.81

Individual variations in serum melatonin levels through time: implications for epidemiologic studies. PLoS One (2013) 0.80

Breast cancer risk and night shift work in a case-control study in a Spanish population. Eur J Epidemiol (2015) 0.80

Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype. Cancer Invest (2014) 0.78

Circadian rhythms in liver metabolism and disease. Acta Pharm Sin B (2015) 0.78

Shift work and breast cancer: do we need more evidence and what should this be? Occup Environ Med (2013) 0.77

Research into 'night shift work' and cancer: on the evolution of 'exposure' classification. Occup Environ Med (2013) 0.77

The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses. BMC Cancer (2014) 0.76

The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis. Endocr Rev (2016) 0.75

Articles by these authors

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med (2005) 28.25

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71

Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med (2011) 8.19

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst (2005) 5.65

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol (2005) 4.99

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood (2007) 4.31

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86

Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 2.73

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood (2005) 2.69

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

The influence of light at night exposure on melatonin levels among Canadian rotating shift nurses. Cancer Epidemiol Biomarkers Prev (2011) 2.27

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. J Clin Oncol (2014) 2.25

Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol (2002) 2.18

GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. Int J Cancer (2010) 2.18

Characteristics of peaks of inhalation exposure to organic solvents. Ann Occup Hyg (2004) 2.15

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood (2006) 2.15

Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. Pediatr Blood Cancer (2012) 2.11

Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev (2005) 2.10

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res (2014) 2.03

Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer (2008) 2.02

Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol (2012) 1.94

Time trends (1998-2007) in brain cancer incidence rates in relation to mobile phone use in England. Bioelectromagnetics (2011) 1.93

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer (2007) 1.78

Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristics. Pediatr Blood Cancer (2010) 1.78

The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res (2005) 1.76

Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med (2002) 1.73

Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: the Cross-Canada Childhood Leukemia Study. Am J Epidemiol (2007) 1.65

Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58

High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood (2008) 1.55

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol (2006) 1.53

Quantitative analysis of human heart valves: does anorexigen exposure produce a distinctive morphological lesion? Cardiovasc Pathol (2002) 1.47

Cancer incidence of Nordic asphalt workers. Scand J Work Environ Health (2004) 1.45

Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res (2009) 1.45

Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting. Blood (2007) 1.45

Multiple myeloma and occupational exposures: a population-based case-control study. J Occup Environ Med (2011) 1.43

Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer (2007) 1.42

Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer (2005) 1.26

Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol (2009) 1.17

Childhood leukemia and socioeconomic status in Canada. Epidemiology (2005) 1.14

Inside the black box: starting to uncover the underlying decision rules used in a one-by-one expert assessment of occupational exposure in case-control studies. Occup Environ Med (2012) 1.13

Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum (2004) 1.11

Refutation of dirty electricity hypothesis in obesity: epistemological arguments and trans-disciplinary study using an instrumental variable. Electromagn Biol Med (2013) 1.09

Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis (2006) 1.07

Assessing exposure to outdoor lighting and health risks. Epidemiology (2015) 1.06

Evaluating uncertainty to strengthen epidemiologic data for use in human health risk assessments. Environ Health Perspect (2014) 1.06

IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03

Bayesian analysis of a matched case-control study with expert prior information on both the misclassification of exposure and the exposure-disease association. Stat Med (2009) 1.03

Estimating the extent and distribution of new-onset adult asthma in British Columbia using frequentist and Bayesian approaches. Ann Occup Hyg (2012) 1.02

Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2007) 1.01

The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. Eur Heart J (2003) 1.01

HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. J Infect Dis (2007) 1.01

Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. Expert Rev Pharmacoecon Outcomes Res (2010) 1.00

Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health B Crit Rev (2008) 1.00

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis (2010) 1.00

Plasma levels of polychlorinated biphenyls and risk of cutaneous malignant melanoma: a preliminary study. Int J Cancer (2011) 0.99

Cancer mortality among European asphalt workers: an international epidemiological study. II. Exposure to bitumen fume and other agents. Am J Ind Med (2003) 0.98

Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res (2011) 0.98

Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma. BMC Med Genet (2009) 0.97

Relationship of time since childbirth and other pregnancy factors to premenopausal breast cancer prognosis. Obstet Gynecol (2008) 0.97

A database of exposures in the rubber manufacturing industry: design and quality control. Ann Occup Hyg (2005) 0.95

HCV co-infection in HIV positive population in British Columbia, Canada. BMC Public Health (2010) 0.95

Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control (2008) 0.95

Mortality among British Columbians testing for hepatitis C antibody. BMC Public Health (2013) 0.94

Analysis of recurrent events with non-negligible event duration, with application to assessing hospital utilization. Lifetime Data Anal (2010) 0.94

Exposure to wood dust and endotoxin in small-scale wood industries in Tanzania. J Expo Anal Environ Epidemiol (2004) 0.93

Cost-effective prediction of gender-labeling errors and estimation of gender-labeling error rates in candidate-gene association studies. Front Genet (2011) 0.92

Hospitalisations 1998-2000 in a British Columbia population-based cohort of young cancer survivors: report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) Research Program. Eur J Cancer (2010) 0.92

Cancer mortality among European asphalt workers: an international epidemiological study. I. Results of the analysis based on job titles. Am J Ind Med (2003) 0.92

The ghost of methods past: exposure assessment versus job-exposure matrix studies. Occup Environ Med (2010) 0.92

Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol (2011) 0.92

Dichotomization: 2 x 2 (x2 x 2 x 2...) categories: infinite possibilities. BMC Med Res Methodol (2010) 0.92

Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells. BMC Cancer (2012) 0.92

Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control (2009) 0.92

The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. Am Heart J (2006) 0.91

Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol (2015) 0.91

Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancer. Oncologist (2012) 0.91

The challenge of defining normality for human mitral and aortic valves: geometrical and compositional analysis. Cardiovasc Pathol (2002) 0.91

Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open Med (2007) 0.91

Birth order and risk of non-hodgkin lymphoma--true association or bias? Am J Epidemiol (2010) 0.91

Smoking and other lifestyle factors in relation to erectile dysfunction. BJU Int (2005) 0.90

Bias in the estimation of exposure effects with individual- or group-based exposure assessment. J Expo Sci Environ Epidemiol (2010) 0.90

Mortality following unemployment in Canada, 1991-2001. BMC Public Health (2013) 0.89

Late morbidity leading to hospitalization among 5-year survivors of young adult cancer: a report of the childhood, adolescent and young adult cancer survivors research program. Int J Cancer (2013) 0.89

Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix. Int J Cancer (2012) 0.89

Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood (2003) 0.89

Shift work, circadian gene variants and risk of breast cancer. Cancer Epidemiol (2013) 0.89